Hirosaki University Hospital

Hirosaki-shi, Aomori 036-8563

2 studies enrolling now · 8 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Atherosclerotic Cardiovascular Disease, Gastric Cancer, Gastroesophageal Junction Cancer, Heart Failure, Immunoglobulin A Nephropathy (IgAN), Non-Small Cell Lung Cancer (NSCLC), Ulcerative Colitis

Studies at this site

• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) — Recruiting now
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. — Stopped early
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
• Advance Cardiac Resynchronization Therapy (CRT) Registry — Completed